Actuate Therapeutics, Inc.
ACTU
$1.32
-$0.05-3.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.83M | 12.20M | 12.20M | 12.52M | 10.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.77M | 21.84M | 22.50M | 24.37M | 24.29M |
| Operating Income | -20.77M | -21.84M | -22.50M | -24.37M | -24.29M |
| Income Before Tax | -20.45M | -21.54M | -22.23M | -24.12M | -24.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.45 | -21.54 | -22.23 | -24.12 | -24.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.45M | -21.54M | -22.23M | -24.12M | -24.68M |
| EBIT | -20.77M | -21.84M | -22.50M | -24.37M | -24.29M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.89 | -0.99 | -1.07 | -1.21 | -1.51 |
| Normalized Basic EPS | -0.56 | -0.62 | -0.67 | -0.76 | -0.88 |
| EPS Diluted | -0.89 | -0.99 | -1.07 | -1.21 | -1.51 |
| Normalized Diluted EPS | -0.56 | -0.62 | -0.67 | -0.76 | -0.88 |
| Average Basic Shares Outstanding | 92.33M | 88.11M | 84.07M | 80.09M | 69.47M |
| Average Diluted Shares Outstanding | 92.33M | 88.11M | 84.07M | 80.09M | 69.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |